(2026). Adjuvant nivolumab in resected oesophageal or gastroesophageal junction cancer following neoadjuvant chemoradiotherapy: Slovenian real-world data. Radiology and Oncology.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Adjuvant Nivolumab in Resected Oesophageal or Gastroesophageal Junction Cancer Following Neoadjuvant Chemoradiotherapy: Slovenian Real-world Data."
Radiology and Oncology 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Adjuvant Nivolumab in Resected Oesophageal or Gastroesophageal Junction Cancer Following Neoadjuvant Chemoradiotherapy: Slovenian Real-world Data."
Radiology and Oncology, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.